Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Contract Type
credit_agreement
New YorkBiotechnologyPharmaceuticalBiopharmaDescription
On December 12, 2025, Fortress Biotech, Inc. entered into the First Amendment to its Credit Agreement with Oaktree Fund Administration, LLC. This amendment allows the Company to extend the maturity date of its loan from July 25, 2027, to June 30, 2028. The agreement originally allowed for a borrowing of $35.0 million, with an additional $15.0 million available upon lender consent
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months